ABIVAX Société Anonyme (AAVXF)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,389	443	680	111	531	582
Market Cap Growth	-56.49%	-34.81%	513.79%	-79.15%	-8.73%	95.59%
Enterprise Value	5,393	330	611	135	563	597
Last Close Price	71.02	7.37	10.19	5.79	32.00	41.00
PS Ratio	470.92	39.67	134.50	23.01	111.15	33992.46
PB Ratio	-756.39	10.55	3.14	14.42	18.01	26.59
P/TBV Ratio	-	27.52	3.60	-	-	-
EV/Sales Ratio	-	29.58	120.88	27.95	117.68	34879.88
Debt / Equity Ratio	-16.16	2.69	0.38	6.85	1.99	1.90
Asset Turnover	-	0.04	0.02	0.05	0.05	0
Quick Ratio	1.16	1.70	3.09	0.69	2.14	1.92
Current Ratio	1.25	1.82	3.15	0.70	2.34	1.94
Return on Equity (ROE)	-196.12%	-148.98%	-145.41%	-366.75%	-193.69%	-205.80%
Return on Assets (ROA)	-	-40.62%	-39.55%	-34.64%	-34.01%	-40.23%
Return on Capital (ROIC)	-59.22%	-51.45%	-48.71%	-47.76%	-47.43%	-54.26%
Earnings Yield	-3.73%	-41.16%	-24.02%	-58.59%	-9.09%	-7.89%
FCF Yield	-3.07%	-36.13%	-15.83%	-52.31%	-9.65%	-6.46%
Buyback Yield / Dilution	-26.78%	-46.39%	-125.57%	-23.53%	-7.84%	-17.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.